Marie Svensson

  • Independent in relation to the Company and its management: No
  • Independent in relation to major shareholders: Yes
  • Holdings in Alligator: 305,089 shares, 250,000 warrants in program TO 2022/2025 I, 600,000 warrants in program TO 2023/2026 I, 450,000 warrants in program TO 2024/2027 I and 53,839 warrants in program TO 9.
  • Other current positions: Board member of A Bioscience Incentive AB and Atlas Therapeutics AB, Deputy board member in Lemniscus Consulting AB.

Marie Svensson – born 1964, Chief Financial Officer since 2020 – has a Bachelor of Science in accounting and a Master of Business Administration/Management from Lund University. Marie has more than 20 years of experience from various financial positions in the high-tech industry. Employed since 2020 and member of the Management Team since 2020.

Updated 2024-05-21